• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, February 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Glycans at the ‘I’ of the storm in humoral immunity and melanoma progression

Bioengineer by Bioengineer
August 22, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Charles Dimitroff, Brigham and Women's Hospital

Two new studies have unveiled how a peculiar molecule impacts how antibody-producing cells develop and function as well as how normal melanocytes progress to melanoma malignancy.

"These findings on fundamental immunology and melanoma development originate from totally different areas of research, though have intersected at the bench," said Charles Dimitroff, PhD, of the Department of Dermatology at Brigham and Women's Hospital.

The Dimitroff lab, along with collaborators at Imperial College London, recently published two back-to-back-articles in the journal, Nature Communications, detailing novel findings on cell surface carbohydrates ('glycans') regulating human B cell function and human melanoma progression – two scientific areas seemingly at the opposite ends of the research spectrum. Over a five-year period in the Dimitroff laboratory, Nicholas Giovannone, PhD, and Jenna Geddes Sweeney, PhD, who were investigating the global glycan features of human B cells at various stages of differentiation and of normal and malignant melanocytes, independently discovered that a distinct glycan feature known as blood group I-antigen or "I-branches" was remarkably central to glycan-mediated processes regulating both human B cell signaling/activation and melanoma aggressiveness. Precisely how these I-branch features control B cell differentiation and humoral immunity or drive melanoma progression are still under intense investigation and likely to reveal new targets for immunomodulation or anti-cancer treatments.

###

Papers cited: Gionvannone, N et al. "Galectin-9 suppresses B cell receptor signaling andis regulated by I-branching of N-glycans." Nature Communications DOI: 10.1038/s41467-018-05770-9 Sweeney GS et al. "Loss of GCNT2/I-branched glycans enhancesmelanoma growth and survival" Nature Communications DOI: 10.1038/s41467-018-05795-0

Media Contact

Haley Bridger
[email protected]
617-525-6383
@BrighamWomens

http://www.brighamandwomens.org

Related Journal Article

http://dx.doi.org/10.1038/s41467-018-05770-9

Share12Tweet7Share2ShareShareShare1

Related Posts

Impact of High-Fat Diet on Empagliflozin Pharmacokinetics

February 9, 2026

Analyzing Elderly Care Needs Using Kano Model

February 9, 2026

Triple Targeting Enhances CXCL16–CXCR6 Antitumor Response

February 9, 2026

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

February 9, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Mapping Tertiary Lymphoid Structures for Kidney Cancer Biomarkers

    50 shares
    Share 20 Tweet 13
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Chronic Alcohol Consumption Alters Gene Expression in Crucial Brain Regions Associated with Relapse Risk and Neural Injury

Impact of High-Fat Diet on Empagliflozin Pharmacokinetics

Analyzing Elderly Care Needs Using Kano Model

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 74 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.